Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum. ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
Breast Cancer (Expert Forum)
Chemo for elderly women
Questions posted in the Breast Cancer Forum are answered by medical professionals from The Cleveland Clinic. Topics include Breast Biopsy, Chemotherapy, Hormone Therapy, Lumps, Lumpectomy, Lymph node dissection, Lymphedema, Mammograms, Mastectomy, Radiation Therapy, Reconstruction, Self Breast Exam, and Surgery.
Chemo for elderly women
by Nano, Aug 29, 2001 12:00AM
I have a friend who is 86 years old and recently had a mastectomy on her left side. Her tumor was ER-neg., 2.5 cm, aggressive, with 3 lymph nodes positive. She has a history of heart problems ( recent angioplasty and is on coumadin), and tends to be anemic. She has also been on Estrogen for 50 years due to a hysterectomy at 35. She is still on Estrogen. Her doctor wants to do chemotherapy - CMF protocol - 6 rounds every 3 weeks. I think she might be too fragile for this and wonder about the necessity of having her go through this treatment when the doctor says it will give her a 15-20% chance of not having a reoccurence. I know everyone is different, but at her age, and given her health, is this an appropriate protocol for her??
Nano
Nano
Doctor's Answer
by CCF-RN,MSN-JS, Aug 30, 2001 12:00AM
Dear Nano, Chemotherapy CMF has been recommended to your friend as adjuvant therapy. Adjuvant treatment is given after surgery to try to prevent or minimize the growth of microscopic deposits of tumor cells that might grow into a recurrent tumor. In a Stage IIB situation (tumor larger than 2 cm and positive lymph nodes) the possibility that the tumor has spread is greater. Because her tumor was estrogen receptor negative this is why they are recommending chemotherapy rather than tamoxifen. The CMF combination was most likely chosen as the methotrexate has less cardiac toxicity associated with it than other drugs that are commonly used in combination adjuvant therapy. Treatment lasts four to six months in most adjuvant programs.
Whether to proceed with chemotherapy in consideration of her age, health status, and quality of life would need to be up to her. This, of course, after discussion of all of the risks (potential side effects of the treatment taking into account her other health problems), and benefits (prevention or minimization of the growth of possible microscopic deposits of tumor cells that may grow into a recurrent tumor). Each person differs in terms of the importance they might place on the risks and benefits of treatment.
Whether to proceed with chemotherapy in consideration of her age, health status, and quality of life would need to be up to her. This, of course, after discussion of all of the risks (potential side effects of the treatment taking into account her other health problems), and benefits (prevention or minimization of the growth of possible microscopic deposits of tumor cells that may grow into a recurrent tumor). Each person differs in terms of the importance they might place on the risks and benefits of treatment.
